Singapore-based firm to start human trials for Covid-19 treatment


Team Udayavani, Jun 12, 2020, 11:02 AM IST

Tychan, Singaporean biotechnology firm,  will begin human clinical trials next week for a potential monoclonal antibody treatment for Covid-19

The first phase of the trial will be conducted on healthy volunteers to determine the safety and tolerability of TY027, a monoclonal antibody or immune system protein that specifically targets the virus that causes Covid-19.

TY027 is being explored for its ability to slow down the progression of Covid-19 and speed up recovery, and its potential to provide temporary protection against infection

It is said that if phase one is successful, Tychan will seek approval for the antibody to be administered to a larger population of volunteer patients in subsequent trials.

 

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

EVMs destroyed as two groups of villagers clash in Chamarajanagar district

Banjarumale hamlet in Belthangady records 100 per cent voting

Board exams twice a year from 2025: MoE asks CBSE to work out logistics, no plan for semesters

Lok Sabha 2024: Tribal hamlet of Banjarumale in Belthangady records 100% voter turnout

Padubidri: Speeding car collides with electric pole, one dead

Bengaluru eateries butter up voter turnout with free dosa

Low voter turnout in Karnataka: Only 38.23% cast votes in 14 LS segments during first half of the day

Related Articles More

China says talks on Tibet only with Dalai Lama’s representatives; rules out dialogue on autonomy

Indian-origin man shot, killed by San Antonio police amid attempts to apprehend him

2 Indian restaurants in Colorado duped investors of USD 380K: Officials

WATCH: 5 runaway military horses cause mayhem in London

Don’t blame Dubai’s freak rain on cloud seeding

MUST WATCH

Skin Rash, Causes, Signs and Symptoms

11 bullets found in python’s body!

K. Jayaprakash Hegde Sharing His Memories

Grafting Jack Anil

Heat Illness


Latest Additions

Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business

Congress to discuss candidates for Amethi, Raebareli seats on Saturday

BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post

Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm

‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.